Rank | Gene Set | Z-score |
---|---|---|
1 | cilium movement (GO:0003341) | 8.00651639 |
2 | axoneme assembly (GO:0035082) | 7.82459022 |
3 | axonemal dynein complex assembly (GO:0070286) | 6.23831539 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.58172935 |
5 | central nervous system myelination (GO:0022010) | 5.24089266 |
6 | axon ensheathment in central nervous system (GO:0032291) | 5.24089266 |
7 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.07676706 |
8 | epithelial cilium movement (GO:0003351) | 4.76724773 |
9 | ventricular system development (GO:0021591) | 4.76623966 |
10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.66895174 |
11 | respiratory electron transport chain (GO:0022904) | 4.47942525 |
12 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.47760267 |
13 | ATP synthesis coupled proton transport (GO:0015986) | 4.47760267 |
14 | GTP biosynthetic process (GO:0006183) | 4.40807819 |
15 | electron transport chain (GO:0022900) | 4.35440034 |
16 | left/right axis specification (GO:0070986) | 4.35314455 |
17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.30882709 |
18 | L-phenylalanine catabolic process (GO:0006559) | 4.30882709 |
19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.26775865 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.07850004 |
21 | UTP metabolic process (GO:0046051) | 4.03242453 |
22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.00860984 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.98660193 |
24 | L-phenylalanine metabolic process (GO:0006558) | 3.98660193 |
25 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.91018378 |
26 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.77369938 |
27 | UTP biosynthetic process (GO:0006228) | 3.75457647 |
28 | regulation of triglyceride catabolic process (GO:0010896) | 3.71691531 |
29 | respiratory chain complex IV assembly (GO:0008535) | 3.70890286 |
30 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.70546208 |
31 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69086669 |
32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.68543708 |
33 | proteasome assembly (GO:0043248) | 3.63680459 |
34 | regulation of cholesterol esterification (GO:0010872) | 3.57895026 |
35 | cysteine metabolic process (GO:0006534) | 3.57649930 |
36 | cholesterol biosynthetic process (GO:0006695) | 3.57035389 |
37 | regulation of macrophage chemotaxis (GO:0010758) | 3.56661192 |
38 | tricarboxylic acid cycle (GO:0006099) | 3.54330392 |
39 | very long-chain fatty acid metabolic process (GO:0000038) | 3.49752879 |
40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.49404638 |
41 | xenobiotic catabolic process (GO:0042178) | 3.47666421 |
42 | aromatic amino acid family catabolic process (GO:0009074) | 3.45688872 |
43 | sterol biosynthetic process (GO:0016126) | 3.44027378 |
44 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.43643838 |
45 | negative regulation of ligase activity (GO:0051352) | 3.43643838 |
46 | branched-chain amino acid catabolic process (GO:0009083) | 3.41727824 |
47 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.40732200 |
48 | cytochrome complex assembly (GO:0017004) | 3.40477865 |
49 | amino-acid betaine metabolic process (GO:0006577) | 3.40448566 |
50 | chaperone-mediated protein transport (GO:0072321) | 3.40323854 |
51 | cellular response to cholesterol (GO:0071397) | 3.38792915 |
52 | C4-dicarboxylate transport (GO:0015740) | 3.34798964 |
53 | cellular ketone body metabolic process (GO:0046950) | 3.34737093 |
54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.33158620 |
55 | oxidative phosphorylation (GO:0006119) | 3.32363924 |
56 | regulation of oxidative phosphorylation (GO:0002082) | 3.30695974 |
57 | glyoxylate metabolic process (GO:0046487) | 3.30022696 |
58 | carnitine metabolic process (GO:0009437) | 3.26127825 |
59 | bile acid biosynthetic process (GO:0006699) | 3.24631428 |
60 | cellular response to zinc ion (GO:0071294) | 3.23541369 |
61 | aspartate family amino acid catabolic process (GO:0009068) | 3.22320400 |
62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.22169794 |
63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.22169794 |
64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.22169794 |
65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.21956276 |
66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.21956276 |
67 | fatty acid homeostasis (GO:0055089) | 3.21937798 |
68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.20752762 |
69 | fatty acid elongation (GO:0030497) | 3.20262619 |
70 | oligodendrocyte differentiation (GO:0048709) | 3.19843842 |
71 | cellular response to sterol (GO:0036315) | 3.17074880 |
72 | reverse cholesterol transport (GO:0043691) | 3.16303605 |
73 | aldehyde catabolic process (GO:0046185) | 3.15750758 |
74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.14199595 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.13752794 |
76 | protein-lipid complex remodeling (GO:0034368) | 3.13752794 |
77 | macromolecular complex remodeling (GO:0034367) | 3.13752794 |
78 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12510359 |
79 | thioester biosynthetic process (GO:0035384) | 3.12407374 |
80 | acyl-CoA biosynthetic process (GO:0071616) | 3.12407374 |
81 | short-chain fatty acid metabolic process (GO:0046459) | 3.12315527 |
82 | NADH metabolic process (GO:0006734) | 3.11023900 |
83 | fatty acid beta-oxidation (GO:0006635) | 3.10815268 |
84 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.10148284 |
85 | low-density lipoprotein particle clearance (GO:0034383) | 3.09555821 |
86 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.08832287 |
87 | microtubule bundle formation (GO:0001578) | 3.08692869 |
88 | regulation of mononuclear cell migration (GO:0071675) | 3.08241492 |
89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.07560074 |
90 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.07560074 |
91 | sulfur amino acid catabolic process (GO:0000098) | 3.07488618 |
92 | protein heterotetramerization (GO:0051290) | 3.06478223 |
93 | L-serine metabolic process (GO:0006563) | 3.05984427 |
94 | photoreceptor cell differentiation (GO:0046530) | 3.05304977 |
95 | eye photoreceptor cell differentiation (GO:0001754) | 3.05304977 |
96 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.01956031 |
97 | lipid oxidation (GO:0034440) | 3.01780403 |
98 | plasma lipoprotein particle clearance (GO:0034381) | 3.01177797 |
99 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.00715261 |
100 | regulation of cellular amine metabolic process (GO:0033238) | 2.99841910 |
101 | protein complex biogenesis (GO:0070271) | 2.99231072 |
102 | high-density lipoprotein particle remodeling (GO:0034375) | 2.97708432 |
103 | ketone body metabolic process (GO:1902224) | 2.97164507 |
104 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97005981 |
105 | fatty acid catabolic process (GO:0009062) | 2.94744255 |
106 | thioester metabolic process (GO:0035383) | 2.93780560 |
107 | fatty acid oxidation (GO:0019395) | 2.93444297 |
108 | lactate metabolic process (GO:0006089) | 2.92730499 |
109 | dicarboxylic acid catabolic process (GO:0043649) | 2.89097657 |
110 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.87991551 |
111 | response to methylmercury (GO:0051597) | 2.85359749 |
112 | triglyceride catabolic process (GO:0019433) | 2.85262049 |
113 | hydrogen ion transmembrane transport (GO:1902600) | 2.84032223 |
114 | cellular glucuronidation (GO:0052695) | 2.83789742 |
115 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.83343149 |
116 | establishment of integrated proviral latency (GO:0075713) | 2.82480941 |
117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.81773300 |
118 | signal peptide processing (GO:0006465) | 2.80574769 |
119 | phospholipid efflux (GO:0033700) | 2.79639680 |
120 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.79589693 |
121 | cullin deneddylation (GO:0010388) | 2.79440083 |
122 | regulation of mitochondrial translation (GO:0070129) | 2.78593168 |
123 | regulation of plasminogen activation (GO:0010755) | 2.78386171 |
124 | positive regulation of ligase activity (GO:0051351) | 2.78320036 |
125 | acylglycerol catabolic process (GO:0046464) | 2.77931038 |
126 | neutral lipid catabolic process (GO:0046461) | 2.77931038 |
127 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.77688068 |
128 | positive regulation of fatty acid oxidation (GO:0046321) | 2.76459910 |
129 | protein neddylation (GO:0045116) | 2.76258203 |
130 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75159367 |
131 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.74796437 |
132 | vitamin biosynthetic process (GO:0009110) | 2.73935847 |
133 | linoleic acid metabolic process (GO:0043651) | 2.73157462 |
134 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.72925742 |
135 | regulation of lipid catabolic process (GO:0050994) | 2.72580391 |
136 | ethanol oxidation (GO:0006069) | 2.72026461 |
137 | platelet dense granule organization (GO:0060155) | 2.71745032 |
138 | biotin metabolic process (GO:0006768) | 2.71115744 |
139 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.70470287 |
140 | monocarboxylic acid catabolic process (GO:0072329) | 2.70173523 |
141 | alpha-amino acid catabolic process (GO:1901606) | 2.70125398 |
142 | triglyceride homeostasis (GO:0070328) | 2.69533710 |
143 | acylglycerol homeostasis (GO:0055090) | 2.69533710 |
144 | positive regulation of extracellular matrix organization (GO:1903055) | 2.68885520 |
145 | one-carbon compound transport (GO:0019755) | 2.68441038 |
146 | tryptophan catabolic process (GO:0006569) | 2.68349739 |
147 | indole-containing compound catabolic process (GO:0042436) | 2.68349739 |
148 | indolalkylamine catabolic process (GO:0046218) | 2.68349739 |
149 | complement activation, alternative pathway (GO:0006957) | 2.67530020 |
150 | peroxisome fission (GO:0016559) | 2.67250188 |
151 | ATP biosynthetic process (GO:0006754) | 2.67043035 |
152 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.66365699 |
153 | positive regulation of lipid catabolic process (GO:0050996) | 2.64752529 |
154 | neurotransmitter uptake (GO:0001504) | 2.64547343 |
155 | CTP metabolic process (GO:0046036) | 2.63682026 |
156 | CTP biosynthetic process (GO:0006241) | 2.63682026 |
157 | glucuronate metabolic process (GO:0019585) | 2.62437120 |
158 | uronic acid metabolic process (GO:0006063) | 2.62437120 |
159 | regulation of cholesterol metabolic process (GO:0090181) | 2.62327219 |
160 | tryptophan metabolic process (GO:0006568) | 2.62003051 |
161 | serine family amino acid catabolic process (GO:0009071) | 2.60223761 |
162 | bile acid metabolic process (GO:0008206) | 2.59955028 |
163 | glutamate metabolic process (GO:0006536) | 2.59905924 |
164 | glutathione derivative metabolic process (GO:1901685) | 2.59857403 |
165 | glutathione derivative biosynthetic process (GO:1901687) | 2.59857403 |
166 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.59762685 |
167 | serine family amino acid biosynthetic process (GO:0009070) | 2.59072168 |
168 | cellular amino acid catabolic process (GO:0009063) | 2.57893514 |
169 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.57648726 |
170 | response to nitrosative stress (GO:0051409) | 2.57531984 |
171 | acyl-CoA metabolic process (GO:0006637) | 2.57055522 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.56339977 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.99589648 |
3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.62819218 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.19973957 |
5 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.49613857 |
6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40370412 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38213463 |
8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.37157027 |
9 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.26130447 |
10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.16751442 |
11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.07486624 |
12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.05728255 |
13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.03080206 |
14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.80050415 |
15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.72942812 |
16 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.66907088 |
17 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.59385361 |
18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.48575160 |
19 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.42786108 |
20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.41874150 |
21 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.40498475 |
22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29574256 |
23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.24898244 |
24 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.24037747 |
25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.23477215 |
26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16916333 |
27 | * AR_21909140_ChIP-Seq_LNCAP_Human | 2.14100089 |
28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.11370725 |
29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.05564588 |
30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98088811 |
31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88601867 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88487096 |
33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84387858 |
34 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83917812 |
35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.83882381 |
36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82267159 |
37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76537792 |
38 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.73745835 |
39 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.69783612 |
40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68275396 |
41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67328177 |
42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.66430409 |
43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66338939 |
44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.65859521 |
45 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63969216 |
46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62813975 |
47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55140178 |
48 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54005531 |
49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53716939 |
50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52841898 |
51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.52757296 |
52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50677354 |
53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.50188991 |
54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47533052 |
55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44109444 |
56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42881550 |
57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41026854 |
58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40456329 |
59 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40201532 |
60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.39571145 |
61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.39571145 |
62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38011223 |
63 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37661117 |
64 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.37592406 |
65 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36553713 |
66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35163253 |
67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34957368 |
68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34217796 |
69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32078618 |
70 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31624140 |
71 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30300844 |
72 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.30247986 |
73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26709146 |
74 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26034489 |
75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25424243 |
76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.24774112 |
77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24428434 |
78 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22851578 |
79 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21394282 |
80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21086497 |
81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20783164 |
82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19874595 |
83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19568787 |
84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.17328845 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17118381 |
86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17118381 |
87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16665253 |
88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15997022 |
89 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15506368 |
90 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15461450 |
91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15272656 |
92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14416576 |
93 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.14332052 |
94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13759308 |
95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09667127 |
96 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08058756 |
97 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.07751027 |
98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07406902 |
99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07313623 |
100 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.06921123 |
101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06803238 |
102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.06116786 |
103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05544648 |
104 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05391854 |
105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05156232 |
106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04343525 |
107 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04336331 |
108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04179684 |
109 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03794250 |
110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02034215 |
111 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00824984 |
112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99851476 |
113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99303071 |
114 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99272625 |
115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98547074 |
116 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97180617 |
117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97076663 |
118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97042477 |
119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96697681 |
120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96241757 |
121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96001878 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95948356 |
123 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95762442 |
124 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95112193 |
125 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95040701 |
126 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93970275 |
127 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93786381 |
128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93584233 |
129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93281018 |
130 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.92815483 |
131 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.92167189 |
132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91433997 |
133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.91418099 |
134 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91304811 |
135 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90515679 |
136 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89714758 |
137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89335329 |
138 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88509595 |
139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88261699 |
140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88130916 |
141 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87292392 |
142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85775429 |
143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85735121 |
144 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85618786 |
145 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85618786 |
146 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85282846 |
147 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85175727 |
148 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.85054077 |
149 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85036944 |
150 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.84642921 |
151 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84595062 |
152 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84124140 |
153 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84087685 |
154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84031364 |
155 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.83371137 |
156 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82770341 |
157 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82641817 |
158 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82404949 |
159 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.81926849 |
160 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.81926849 |
161 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.81875713 |
162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81018287 |
163 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80297028 |
164 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79901835 |
165 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.79685126 |
166 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.79227200 |
167 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.79071052 |
168 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.79050815 |
169 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78709733 |
170 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78046650 |
171 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.77835984 |
172 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77603622 |
173 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77307658 |
174 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77097283 |
175 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.76650882 |
176 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76490875 |
177 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.76119737 |
178 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75347348 |
179 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.75280470 |
180 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.74185856 |
181 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73409922 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003136_yellow_coat_color | 5.10527799 |
2 | MP0005360_urolithiasis | 4.85449781 |
3 | MP0002139_abnormal_hepatobiliary_system | 4.57772808 |
4 | MP0003011_delayed_dark_adaptation | 3.20235856 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.14184490 |
6 | MP0003690_abnormal_glial_cell | 3.12196470 |
7 | MP0005365_abnormal_bile_salt | 3.10308833 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.02562606 |
9 | MP0002736_abnormal_nociception_after | 2.75321721 |
10 | MP0010329_abnormal_lipoprotein_level | 2.51415636 |
11 | MP0006036_abnormal_mitochondrial_physio | 2.49398547 |
12 | MP0002653_abnormal_ependyma_morphology | 2.42217391 |
13 | MP0003868_abnormal_feces_composition | 2.40411748 |
14 | MP0005332_abnormal_amino_acid | 2.35152036 |
15 | MP0005670_abnormal_white_adipose | 2.28570883 |
16 | MP0003941_abnormal_skin_development | 2.28385875 |
17 | MP0009840_abnormal_foam_cell | 2.18205440 |
18 | MP0005408_hypopigmentation | 2.11777274 |
19 | MP0004381_abnormal_hair_follicle | 2.02049891 |
20 | MP0005058_abnormal_lysosome_morphology | 1.84301397 |
21 | MP0003252_abnormal_bile_duct | 1.83782675 |
22 | MP0003186_abnormal_redox_activity | 1.80053447 |
23 | MP0003329_amyloid_beta_deposits | 1.79142052 |
24 | MP0009384_cardiac_valve_regurgitation | 1.75904980 |
25 | MP0004858_abnormal_nervous_system | 1.75518512 |
26 | MP0004019_abnormal_vitamin_homeostasis | 1.74395494 |
27 | MP0002163_abnormal_gland_morphology | 1.73054429 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.68321682 |
29 | MP0003634_abnormal_glial_cell | 1.67597108 |
30 | MP0002249_abnormal_larynx_morphology | 1.60941672 |
31 | MP0000920_abnormal_myelination | 1.54974522 |
32 | MP0002909_abnormal_adrenal_gland | 1.52776724 |
33 | MP0002254_reproductive_system_inflammat | 1.51698853 |
34 | MP0001727_abnormal_embryo_implantation | 1.49083057 |
35 | MP0001666_abnormal_nutrient_absorption | 1.46464854 |
36 | MP0008058_abnormal_DNA_repair | 1.46253143 |
37 | MP0000372_irregular_coat_pigmentation | 1.43673589 |
38 | MP0005646_abnormal_pituitary_gland | 1.43071702 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.43012798 |
40 | MP0008004_abnormal_stomach_pH | 1.42789272 |
41 | MP0000343_altered_response_to | 1.37693570 |
42 | MP0000604_amyloidosis | 1.37388895 |
43 | MP0001661_extended_life_span | 1.37344895 |
44 | MP0002837_dystrophic_cardiac_calcinosis | 1.37074654 |
45 | MP0006072_abnormal_retinal_apoptosis | 1.35466796 |
46 | MP0003191_abnormal_cellular_cholesterol | 1.33842837 |
47 | MP0006054_spinal_hemorrhage | 1.32898578 |
48 | MP0005623_abnormal_meninges_morphology | 1.32820949 |
49 | MP0005083_abnormal_biliary_tract | 1.32531903 |
50 | MP0001485_abnormal_pinna_reflex | 1.30372220 |
51 | MP0001440_abnormal_grooming_behavior | 1.27661287 |
52 | MP0010094_abnormal_chromosome_stability | 1.27526960 |
53 | MP0005253_abnormal_eye_physiology | 1.25187807 |
54 | MP0005666_abnormal_adipose_tissue | 1.24402678 |
55 | MP0003195_calcinosis | 1.18150202 |
56 | MP0002638_abnormal_pupillary_reflex | 1.17242234 |
57 | MP0002282_abnormal_trachea_morphology | 1.15692325 |
58 | MP0006082_CNS_inflammation | 1.15411567 |
59 | MP0009643_abnormal_urine_homeostasis | 1.14293840 |
60 | MP0002971_abnormal_brown_adipose | 1.13649627 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.13215410 |
62 | MP0004885_abnormal_endolymph | 1.13106520 |
63 | MP0003724_increased_susceptibility_to | 1.10847134 |
64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09034291 |
65 | MP0003075_altered_response_to | 1.06909333 |
66 | MP0002876_abnormal_thyroid_physiology | 1.06545287 |
67 | MP0000609_abnormal_liver_physiology | 1.06480194 |
68 | MP0003950_abnormal_plasma_membrane | 1.05341541 |
69 | MP0003718_maternal_effect | 1.05030734 |
70 | MP0001905_abnormal_dopamine_level | 1.04302488 |
71 | MP0000579_abnormal_nail_morphology | 1.03779055 |
72 | MP0005647_abnormal_sex_gland | 1.01642876 |
73 | MP0005379_endocrine/exocrine_gland_phen | 0.99098546 |
74 | MP0001881_abnormal_mammary_gland | 0.98554867 |
75 | MP0001529_abnormal_vocalization | 0.98321395 |
76 | MP0001968_abnormal_touch/_nociception | 0.97864615 |
77 | MP0004130_abnormal_muscle_cell | 0.97617327 |
78 | MP0005171_absent_coat_pigmentation | 0.97608980 |
79 | MP0002796_impaired_skin_barrier | 0.96966127 |
80 | MP0008007_abnormal_cellular_replicative | 0.96763329 |
81 | MP0005448_abnormal_energy_balance | 0.96230444 |
82 | MP0001958_emphysema | 0.95895934 |
83 | MP0004742_abnormal_vestibular_system | 0.93843791 |
84 | MP0005275_abnormal_skin_tensile | 0.92392153 |
85 | MP0002970_abnormal_white_adipose | 0.92021470 |
86 | MP0000516_abnormal_urinary_system | 0.91965830 |
87 | MP0005367_renal/urinary_system_phenotyp | 0.91965830 |
88 | MP0005319_abnormal_enzyme/_coenzyme | 0.91770037 |
89 | MP0002078_abnormal_glucose_homeostasis | 0.90931622 |
90 | MP0002148_abnormal_hypersensitivity_rea | 0.90629204 |
91 | MP0002090_abnormal_vision | 0.90241819 |
92 | MP0001853_heart_inflammation | 0.89080984 |
93 | MP0005451_abnormal_body_composition | 0.87665939 |
94 | MP0002295_abnormal_pulmonary_circulatio | 0.87057869 |
95 | MP0004272_abnormal_basement_membrane | 0.86879762 |
96 | MP0000383_abnormal_hair_follicle | 0.85948024 |
97 | MP0000647_abnormal_sebaceous_gland | 0.85119904 |
98 | MP0004142_abnormal_muscle_tone | 0.83759494 |
99 | MP0002168_other_aberrant_phenotype | 0.82691093 |
100 | MP0009115_abnormal_fat_cell | 0.82585279 |
101 | MP0005636_abnormal_mineral_homeostasis | 0.82127840 |
102 | MP0005166_decreased_susceptibility_to | 0.81957908 |
103 | MP0009379_abnormal_foot_pigmentation | 0.81893831 |
104 | MP0005165_increased_susceptibility_to | 0.81551634 |
105 | MP0005084_abnormal_gallbladder_morpholo | 0.79676591 |
106 | MP0005671_abnormal_response_to | 0.77275998 |
107 | MP0009785_altered_susceptibility_to | 0.76666483 |
108 | MP0005452_abnormal_adipose_tissue | 0.76541021 |
109 | MP0004133_heterotaxia | 0.74541929 |
110 | MP0001177_atelectasis | 0.74530616 |
111 | MP0001756_abnormal_urination | 0.74449405 |
112 | MP0000462_abnormal_digestive_system | 0.74038646 |
113 | MP0008872_abnormal_physiological_respon | 0.73273145 |
114 | MP0001764_abnormal_homeostasis | 0.73209627 |
115 | MP0003633_abnormal_nervous_system | 0.72331871 |
116 | MP0005551_abnormal_eye_electrophysiolog | 0.72182460 |
117 | MP0002133_abnormal_respiratory_system | 0.71737937 |
118 | MP0005388_respiratory_system_phenotype | 0.71737937 |
119 | MP0003172_abnormal_lysosome_physiology | 0.71552168 |
120 | MP0005535_abnormal_body_temperature | 0.70915323 |
121 | MP0002089_abnormal_postnatal_growth/wei | 0.70488829 |
122 | MP0005595_abnormal_vascular_smooth | 0.70087887 |
123 | MP0004185_abnormal_adipocyte_glucose | 0.69740367 |
124 | MP0002928_abnormal_bile_duct | 0.69737828 |
125 | MP0000026_abnormal_inner_ear | 0.69631944 |
126 | MP0006035_abnormal_mitochondrial_morpho | 0.69559907 |
127 | MP0008469_abnormal_protein_level | 0.69201316 |
128 | MP0004043_abnormal_pH_regulation | 0.68963652 |
129 | MP0000778_abnormal_nervous_system | 0.68315133 |
130 | MP0005167_abnormal_blood-brain_barrier | 0.67881194 |
131 | MP0003123_paternal_imprinting | 0.67291988 |
132 | MP0005220_abnormal_exocrine_pancreas | 0.67111262 |
133 | MP0003953_abnormal_hormone_level | 0.66836631 |
134 | MP0001984_abnormal_olfaction | 0.66738801 |
135 | MP0003938_abnormal_ear_development | 0.66674679 |
136 | MP0003656_abnormal_erythrocyte_physiolo | 0.65197837 |
137 | MP0001851_eye_inflammation | 0.64964621 |
138 | MP0010307_abnormal_tumor_latency | 0.64109704 |
139 | MP0003638_abnormal_response/metabolism_ | 0.63835780 |
140 | MP0010678_abnormal_skin_adnexa | 0.63682516 |
141 | MP0001944_abnormal_pancreas_morphology | 0.63203674 |
142 | MP0002938_white_spotting | 0.62644892 |
143 | MP0001501_abnormal_sleep_pattern | 0.62108501 |
144 | MP0010386_abnormal_urinary_bladder | 0.61650863 |
145 | MP0000358_abnormal_cell_content/ | 0.60805344 |
146 | MP0005164_abnormal_response_to | 0.60700495 |
147 | MP0003937_abnormal_limbs/digits/tail_de | 0.60242019 |
148 | MP0001486_abnormal_startle_reflex | 0.59550632 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.82372125 |
2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 9.73727342 |
3 | Abnormal ciliary motility (HP:0012262) | 9.21062927 |
4 | Rhinitis (HP:0012384) | 8.57932412 |
5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.57756944 |
6 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.57756944 |
7 | Chronic bronchitis (HP:0004469) | 5.11777987 |
8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.44439432 |
9 | Increased serum pyruvate (HP:0003542) | 4.39244554 |
10 | Mitochondrial inheritance (HP:0001427) | 4.18734792 |
11 | Bronchiectasis (HP:0002110) | 4.17188354 |
12 | Abnormality of glycolysis (HP:0004366) | 4.00034708 |
13 | Increased CSF lactate (HP:0002490) | 3.91932958 |
14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.75000942 |
15 | Hepatic necrosis (HP:0002605) | 3.66477919 |
16 | Hyperglycinuria (HP:0003108) | 3.59947634 |
17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.58719462 |
18 | Renal Fanconi syndrome (HP:0001994) | 3.53762277 |
19 | Abnormality of glycine metabolism (HP:0010895) | 3.49308975 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.49308975 |
21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.46108935 |
22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.46108935 |
23 | Hepatocellular necrosis (HP:0001404) | 3.40724176 |
24 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.36518677 |
25 | Absent/shortened dynein arms (HP:0200106) | 3.36518677 |
26 | Xanthomatosis (HP:0000991) | 3.32017547 |
27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.27002452 |
28 | Intrahepatic cholestasis (HP:0001406) | 3.26218997 |
29 | Recurrent sinusitis (HP:0011108) | 3.20976033 |
30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.15545639 |
31 | Respiratory failure (HP:0002878) | 3.12337756 |
32 | Abnormal biliary tract physiology (HP:0012439) | 2.95082862 |
33 | Bile duct proliferation (HP:0001408) | 2.95082862 |
34 | Lactic acidosis (HP:0003128) | 2.91328511 |
35 | Generalized aminoaciduria (HP:0002909) | 2.88985656 |
36 | Abnormality of serum amino acid levels (HP:0003112) | 2.82867653 |
37 | Systemic lupus erythematosus (HP:0002725) | 2.81986983 |
38 | Hypoglycemic seizures (HP:0002173) | 2.81095849 |
39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.80924472 |
40 | Multiple enchondromatosis (HP:0005701) | 2.78970723 |
41 | Deep venous thrombosis (HP:0002625) | 2.78938674 |
42 | True hermaphroditism (HP:0010459) | 2.78253247 |
43 | Leukodystrophy (HP:0002415) | 2.77853114 |
44 | Nausea (HP:0002018) | 2.74713997 |
45 | Back pain (HP:0003418) | 2.74579149 |
46 | Hyperlipoproteinemia (HP:0010980) | 2.73228140 |
47 | Ketosis (HP:0001946) | 2.73108978 |
48 | Vacuolated lymphocytes (HP:0001922) | 2.72101752 |
49 | Increased muscle lipid content (HP:0009058) | 2.70097874 |
50 | Exertional dyspnea (HP:0002875) | 2.67363470 |
51 | Increased serum lactate (HP:0002151) | 2.67043462 |
52 | Pancreatic fibrosis (HP:0100732) | 2.63639428 |
53 | CNS demyelination (HP:0007305) | 2.61247343 |
54 | Hyperammonemia (HP:0001987) | 2.58178653 |
55 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58157816 |
56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58157816 |
57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58157816 |
58 | Hypobetalipoproteinemia (HP:0003563) | 2.54170803 |
59 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51485847 |
60 | Poor head control (HP:0002421) | 2.50752216 |
61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.50700808 |
62 | Abnormality of the axillary hair (HP:0100134) | 2.50071236 |
63 | Abnormality of secondary sexual hair (HP:0009888) | 2.50071236 |
64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.49626779 |
65 | Abnormality of methionine metabolism (HP:0010901) | 2.49553442 |
66 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.48941990 |
67 | Median cleft lip (HP:0000161) | 2.48836263 |
68 | Hyperglycinemia (HP:0002154) | 2.48701337 |
69 | Exercise intolerance (HP:0003546) | 2.48633126 |
70 | Symptomatic seizures (HP:0011145) | 2.47951413 |
71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45360512 |
72 | Nasal polyposis (HP:0100582) | 2.44262632 |
73 | Neurofibrillary tangles (HP:0002185) | 2.43233580 |
74 | Ketoacidosis (HP:0001993) | 2.42461829 |
75 | Esophageal neoplasm (HP:0100751) | 2.40506696 |
76 | Neoplasm of head and neck (HP:0012288) | 2.40506696 |
77 | Abnormality of urine glucose concentration (HP:0011016) | 2.40216016 |
78 | Glycosuria (HP:0003076) | 2.40216016 |
79 | Hypoglycemic coma (HP:0001325) | 2.39173527 |
80 | Hypoalphalipoproteinemia (HP:0003233) | 2.38493120 |
81 | Neonatal short-limb short stature (HP:0008921) | 2.35659655 |
82 | Megalencephaly (HP:0001355) | 2.34599727 |
83 | Hypolipoproteinemia (HP:0010981) | 2.33243057 |
84 | Neoplasm of the adrenal gland (HP:0100631) | 2.32791843 |
85 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32278799 |
86 | Methylmalonic acidemia (HP:0002912) | 2.31282324 |
87 | Prolonged partial thromboplastin time (HP:0003645) | 2.26117010 |
88 | Sex reversal (HP:0012245) | 2.22519261 |
89 | Abnormal sex determination (HP:0012244) | 2.22519261 |
90 | Abdominal situs inversus (HP:0003363) | 2.21945567 |
91 | Abnormality of abdominal situs (HP:0011620) | 2.21945567 |
92 | Complement deficiency (HP:0004431) | 2.21860996 |
93 | Methylmalonic aciduria (HP:0012120) | 2.20597071 |
94 | Type I transferrin isoform profile (HP:0003642) | 2.17010822 |
95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15068600 |
96 | Hemiparesis (HP:0001269) | 2.13577409 |
97 | Hydroxyprolinuria (HP:0003080) | 2.13302678 |
98 | Abnormality of proline metabolism (HP:0010907) | 2.13302678 |
99 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12900966 |
100 | Reduced antithrombin III activity (HP:0001976) | 2.11016462 |
101 | Amyloidosis (HP:0011034) | 2.10701243 |
102 | Glomerulonephritis (HP:0000099) | 2.09558139 |
103 | Delayed CNS myelination (HP:0002188) | 2.07099911 |
104 | Cerebral edema (HP:0002181) | 2.05632382 |
105 | Agnosia (HP:0010524) | 2.05470780 |
106 | Abnormality of dentin (HP:0010299) | 2.04939504 |
107 | Abnormality of the anterior horn cell (HP:0006802) | 2.03854907 |
108 | Degeneration of anterior horn cells (HP:0002398) | 2.03854907 |
109 | Abnormality of renal resorption (HP:0011038) | 2.03216131 |
110 | Axonal loss (HP:0003447) | 2.02947554 |
111 | Optic disc pallor (HP:0000543) | 2.02651259 |
112 | Abnormality of placental membranes (HP:0011409) | 2.02084249 |
113 | Amniotic constriction ring (HP:0009775) | 2.02084249 |
114 | Hyperphosphaturia (HP:0003109) | 1.99875075 |
115 | Postural tremor (HP:0002174) | 1.98376983 |
116 | Bronchitis (HP:0012387) | 1.98214238 |
117 | Steatorrhea (HP:0002570) | 1.97561065 |
118 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95682978 |
119 | Prolonged neonatal jaundice (HP:0006579) | 1.94320667 |
120 | Chronic hepatic failure (HP:0100626) | 1.93472234 |
121 | Spastic paraparesis (HP:0002313) | 1.93107973 |
122 | Abnormal cartilage morphology (HP:0002763) | 1.92216081 |
123 | Bronchomalacia (HP:0002780) | 1.91171121 |
124 | Abnormality of the nasal mucosa (HP:0000433) | 1.90234667 |
125 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89589021 |
126 | Respiratory distress (HP:0002098) | 1.89502392 |
127 | Vomiting (HP:0002013) | 1.88985443 |
128 | Conjunctival hamartoma (HP:0100780) | 1.88724526 |
129 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87861516 |
130 | Recurrent otitis media (HP:0000403) | 1.87603057 |
131 | Opisthotonus (HP:0002179) | 1.87509981 |
132 | Epidermoid cyst (HP:0200040) | 1.86036581 |
133 | Spastic diplegia (HP:0001264) | 1.85649296 |
134 | Acute encephalopathy (HP:0006846) | 1.85138215 |
135 | Fibular hypoplasia (HP:0003038) | 1.84907149 |
136 | Metabolic acidosis (HP:0001942) | 1.84244451 |
137 | Sensorimotor neuropathy (HP:0007141) | 1.83580500 |
138 | Dicarboxylic aciduria (HP:0003215) | 1.83306233 |
139 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83306233 |
140 | Abnormality of the dental root (HP:0006486) | 1.81946730 |
141 | Taurodontia (HP:0000679) | 1.81946730 |
142 | Abnormality of permanent molar morphology (HP:0011071) | 1.81946730 |
143 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.80959473 |
144 | Abnormality of alanine metabolism (HP:0010916) | 1.80959473 |
145 | Hyperalaninemia (HP:0003348) | 1.80959473 |
146 | Abnormality of the dental pulp (HP:0006479) | 1.79692153 |
147 | Renal tubular dysfunction (HP:0000124) | 1.78529143 |
148 | Lethargy (HP:0001254) | 1.73678916 |
149 | Abnormality of molar morphology (HP:0011070) | 1.71272149 |
150 | Abnormality of molar (HP:0011077) | 1.71272149 |
151 | Prenatal maternal abnormality (HP:0002686) | 1.66589145 |
152 | Confusion (HP:0001289) | 1.65844944 |
153 | Occipital encephalocele (HP:0002085) | 1.64990386 |
154 | Fat malabsorption (HP:0002630) | 1.63928221 |
155 | Concave nail (HP:0001598) | 1.62927192 |
156 | Pancreatic cysts (HP:0001737) | 1.62412040 |
157 | Abnormal urine output (HP:0012590) | 1.62281734 |
158 | Aplasia of the phalanges of the hand (HP:0009802) | 1.60728648 |
159 | Aplasia involving bones of the extremities (HP:0009825) | 1.60728648 |
160 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.60728648 |
161 | Postaxial foot polydactyly (HP:0001830) | 1.57688183 |
162 | Tubulointerstitial nephritis (HP:0001970) | 1.57464393 |
163 | Abnormal drinking behavior (HP:0030082) | 1.56590281 |
164 | Polydipsia (HP:0001959) | 1.56590281 |
165 | Pili torti (HP:0003777) | 1.56434082 |
166 | Follicular hyperkeratosis (HP:0007502) | 1.55834144 |
167 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.55538995 |
168 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.55538995 |
169 | Metabolic alkalosis (HP:0200114) | 1.55271127 |
170 | Cerebral inclusion bodies (HP:0100314) | 1.54259096 |
171 | Bifid scrotum (HP:0000048) | 1.53752023 |
172 | Parakeratosis (HP:0001036) | 1.52481308 |
173 | Progressive macrocephaly (HP:0004481) | 1.52037506 |
174 | Acute necrotizing encephalopathy (HP:0006965) | 1.50853520 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 6.06326228 |
2 | PNCK | 4.29805692 |
3 | MST4 | 4.21528253 |
4 | SIK1 | 3.65672303 |
5 | MAP3K12 | 3.50106561 |
6 | VRK2 | 3.14542244 |
7 | EIF2AK3 | 3.13554965 |
8 | NEK1 | 3.02355841 |
9 | PDK2 | 2.94044748 |
10 | EIF2AK1 | 2.78199787 |
11 | BCKDK | 2.76946116 |
12 | STK39 | 2.46503347 |
13 | LMTK2 | 2.36920163 |
14 | STK16 | 2.33291618 |
15 | NME2 | 2.12357202 |
16 | BUB1 | 2.08375388 |
17 | PBK | 2.05917610 |
18 | LRRK2 | 1.98107067 |
19 | NTRK2 | 1.92082738 |
20 | OXSR1 | 1.90407238 |
21 | ZAK | 1.83214767 |
22 | BMPR1B | 1.82146939 |
23 | IRAK2 | 1.76185397 |
24 | MST1R | 1.71657953 |
25 | TESK1 | 1.70947337 |
26 | MAP2K2 | 1.69207639 |
27 | ROCK2 | 1.67375055 |
28 | MKNK2 | 1.66258102 |
29 | PHKG1 | 1.64167947 |
30 | PHKG2 | 1.64167947 |
31 | GRK1 | 1.61053217 |
32 | WNK3 | 1.58473483 |
33 | SRPK1 | 1.51744438 |
34 | CDC7 | 1.49413652 |
35 | GSK3A | 1.46783237 |
36 | PLK3 | 1.41421107 |
37 | SGK223 | 1.34381079 |
38 | SGK494 | 1.34381079 |
39 | CSNK1G2 | 1.33607250 |
40 | BRSK2 | 1.31815506 |
41 | NUAK1 | 1.31530599 |
42 | ACVR1B | 1.31488573 |
43 | TTK | 1.31080795 |
44 | EPHB1 | 1.28756033 |
45 | STK10 | 1.27920707 |
46 | TRIB3 | 1.27017701 |
47 | PLK2 | 1.26577867 |
48 | ROCK1 | 1.22057695 |
49 | MAPKAPK5 | 1.21503310 |
50 | ERBB3 | 1.20165751 |
51 | PKN1 | 1.18595305 |
52 | PAK4 | 1.17537886 |
53 | IRAK1 | 1.16538519 |
54 | CASK | 1.14476606 |
55 | MYLK | 1.12840144 |
56 | TRIM28 | 1.12182734 |
57 | WNK4 | 1.10713668 |
58 | BCR | 1.10636708 |
59 | FRK | 1.10223070 |
60 | TYRO3 | 1.09935629 |
61 | CSNK1G1 | 1.08287403 |
62 | ERBB4 | 1.04862489 |
63 | STK38L | 1.04346351 |
64 | PAK2 | 1.02577516 |
65 | MUSK | 1.00534330 |
66 | TSSK6 | 0.98899633 |
67 | LIMK1 | 0.97967999 |
68 | MKNK1 | 0.97784414 |
69 | MET | 0.97631047 |
70 | BMPR2 | 0.97259999 |
71 | MAPK12 | 0.95150381 |
72 | NME1 | 0.94815153 |
73 | DAPK1 | 0.94675540 |
74 | PLK4 | 0.94650449 |
75 | ADRBK1 | 0.93019892 |
76 | NLK | 0.92166507 |
77 | ABL2 | 0.86293485 |
78 | PAK3 | 0.84870146 |
79 | SCYL2 | 0.84116450 |
80 | CCNB1 | 0.82890030 |
81 | PLK1 | 0.82876857 |
82 | NEK9 | 0.81927770 |
83 | VRK1 | 0.80914113 |
84 | TAF1 | 0.79713150 |
85 | EIF2AK2 | 0.79161228 |
86 | BRSK1 | 0.78604647 |
87 | PRKAA2 | 0.78192274 |
88 | PRKCQ | 0.77659385 |
89 | PRKCE | 0.77485862 |
90 | ERN1 | 0.76911298 |
91 | CDK3 | 0.75009977 |
92 | MAP3K2 | 0.74615590 |
93 | TNIK | 0.74409541 |
94 | CAMK2G | 0.73039611 |
95 | FGFR2 | 0.70875155 |
96 | KDR | 0.70261776 |
97 | PRKACG | 0.69475303 |
98 | ADRBK2 | 0.69242177 |
99 | MAPKAPK3 | 0.68300884 |
100 | MAPK4 | 0.66811439 |
101 | DAPK3 | 0.64959198 |
102 | MAP3K9 | 0.64590027 |
103 | PTK6 | 0.64093854 |
104 | PIK3CG | 0.60898081 |
105 | CAMK2B | 0.60745756 |
106 | PRKCG | 0.59755021 |
107 | CSNK2A1 | 0.59185630 |
108 | PRKACA | 0.57426174 |
109 | PRKG1 | 0.56566928 |
110 | TRPM7 | 0.56041927 |
111 | CSNK1G3 | 0.55989080 |
112 | DAPK2 | 0.55798832 |
113 | CAMK2D | 0.54737814 |
114 | FGFR4 | 0.53981751 |
115 | CSNK2A2 | 0.53887225 |
116 | PRKD1 | 0.51633246 |
117 | DYRK2 | 0.50272088 |
118 | MAPK7 | 0.49804433 |
119 | FGR | 0.48819488 |
120 | AURKB | 0.48440044 |
121 | SGK2 | 0.48325789 |
122 | CAMK2A | 0.47388306 |
123 | NTRK1 | 0.47313520 |
124 | SRC | 0.46786361 |
125 | MAP2K1 | 0.46601883 |
126 | IGF1R | 0.45412719 |
127 | LATS1 | 0.44281210 |
128 | CSNK1A1 | 0.44141958 |
129 | FER | 0.43250146 |
130 | ALK | 0.42340448 |
131 | PIM2 | 0.41347337 |
132 | GRK6 | 0.41135285 |
133 | PRKCZ | 0.41118536 |
134 | DMPK | 0.41063585 |
135 | ABL1 | 0.40869425 |
136 | PRKCA | 0.39783954 |
137 | YES1 | 0.38733898 |
138 | ARAF | 0.38674368 |
139 | TLK1 | 0.38487209 |
140 | CSK | 0.38443505 |
141 | MARK1 | 0.38057037 |
142 | MAP4K2 | 0.37649784 |
143 | ILK | 0.36221191 |
144 | PIK3CA | 0.36167257 |
145 | MOS | 0.35980216 |
146 | PRKD3 | 0.35347574 |
147 | STK24 | 0.35103165 |
148 | ITK | 0.34769022 |
149 | CSNK1E | 0.34527143 |
150 | PRKCH | 0.34331250 |
151 | CSNK1A1L | 0.33738823 |
152 | PRKCI | 0.33394820 |
153 | JAK1 | 0.33373102 |
154 | NEK6 | 0.32252442 |
155 | CDK6 | 0.32059169 |
156 | AKT2 | 0.31975413 |
157 | BMX | 0.31766150 |
158 | TESK2 | 0.31225858 |
159 | WEE1 | 0.30244854 |
160 | OBSCN | 0.29790630 |
161 | GRK7 | 0.29594597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.39717542 |
2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.69541446 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.64747515 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.27437543 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.97904029 |
6 | Protein export_Homo sapiens_hsa03060 | 2.82245503 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.65006338 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.62041350 |
9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.59687872 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56841906 |
11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.47170357 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.33949522 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29278206 |
14 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23838683 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12154228 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09935257 |
17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.08865260 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.05358305 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98647037 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97616261 |
21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82499177 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79517196 |
23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72186772 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70175188 |
25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65604577 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64863504 |
27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60476552 |
28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.59493681 |
29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53573684 |
30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.47806145 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45519622 |
32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44395305 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43450442 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39410442 |
35 | Mismatch repair_Homo sapiens_hsa03430 | 1.35980106 |
36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34441212 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33167039 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.31382929 |
39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30554116 |
40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20925012 |
41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19470815 |
42 | RNA polymerase_Homo sapiens_hsa03020 | 1.16895334 |
43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.13960237 |
44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13157865 |
45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10624796 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07514256 |
47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04978000 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01595560 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00781380 |
50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98471452 |
51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98021580 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97994106 |
53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97425050 |
54 | Ribosome_Homo sapiens_hsa03010 | 0.97101767 |
55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97057205 |
56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94767175 |
57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94186577 |
58 | DNA replication_Homo sapiens_hsa03030 | 0.92994465 |
59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91952657 |
60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89005289 |
61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87212543 |
62 | Asthma_Homo sapiens_hsa05310 | 0.83909082 |
63 | Homologous recombination_Homo sapiens_hsa03440 | 0.81476202 |
64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79763914 |
65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79168744 |
66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78093809 |
67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77620376 |
68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72970372 |
69 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72940197 |
70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71343448 |
71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.71284131 |
72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70863017 |
73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68307731 |
74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62269492 |
75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61871435 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61826445 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.60127162 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58906205 |
79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57436641 |
80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57250780 |
81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55736918 |
82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54646981 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.54519679 |
84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52878616 |
85 | Base excision repair_Homo sapiens_hsa03410 | 0.50249096 |
86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49921972 |
87 | Lysosome_Homo sapiens_hsa04142 | 0.49869441 |
88 | Mineral absorption_Homo sapiens_hsa04978 | 0.49803318 |
89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48105943 |
90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48060034 |
91 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44744684 |
92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42659837 |
93 | Spliceosome_Homo sapiens_hsa03040 | 0.42420121 |
94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42298872 |
95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41243112 |
96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40463579 |
97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38142713 |
98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37873470 |
99 | Allograft rejection_Homo sapiens_hsa05330 | 0.37859618 |
100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37019729 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36450977 |
102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33481912 |
103 | Purine metabolism_Homo sapiens_hsa00230 | 0.32705730 |
104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32308125 |
105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32296076 |
106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31625328 |
107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30251343 |
108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.29897310 |
109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29621561 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29330657 |
111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29258616 |
112 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29189850 |
113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28901717 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27826423 |
115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.27759525 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26604367 |
117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24173852 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21587320 |
119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18922997 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16704045 |
121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.14921007 |
122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13144931 |
123 | Lysine degradation_Homo sapiens_hsa00310 | 0.12476640 |
124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.11723522 |
125 | Malaria_Homo sapiens_hsa05144 | 0.11468015 |
126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09556132 |
127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.09121989 |
128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.08640330 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.07399739 |
130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.02794657 |